Dementia in the News

Cure ADvantage (October 5, 2010): What Health Care Reform Means for the Alzheimer's Community

Publication Date: 
Tue, 10/05/2010

Right now, more than five million Americans have Alzheimer's disease, a number that is only expected to increase in the years ahead. I know the pain that Alzheimer's disease can cause - for those diagnosed with it, and for their families and caregivers - which is why my Administration is committed to finding a cure.

Cure Alzheimer's Fund (September 22, 2010): Univ. of Pittsburgh, Mass General Hospital Awarded Alzheimer's Research Grant

Publication Date: 
Wed, 09/22/2010

Bringing together two esteemed institutions known for groundbreaking Alzheimer's research, Cure Alzheimer's Fund has awarded the University of Pittsburgh a $300,00 grant and Massachusetts General Hospital/Harvard (MGH) a $100,000 grant to fund an innovative joint research project on Alzheimer's disease, which currently affects 5.3 billion Americans and their families.

Mass General Magazine (September 20, 2010): Unforgettable Breakthroughs in Alzheimer's

Publication Date: 
Mon, 09/20/2010

Back in the 1980s, it was becoming evident that Alzheimer's disease was an imposing challenge whose weight on health and society was just beginning to be felt. As people began to live longer and the U.S. population began to age, more and more people were finding themselves on the receiving end of a diagnosis of this slow but deadly neurodegenerative disease.

ABC News (September 7, 2010): Cognitive Impairment Strikes Men More

Publication Date: 
Tue, 09/07/2010

Not only do women live longer than men, on average, but a new study from the Mayo Clinic suggests they also may keep their cognitive function longer, too.

In a study of more than 2,000 adults 70 to 89 years old, researchers found that men were 1.5 times more likely to experience mild cognitive decline than their female counterparts.

Los Angeles Times (September 1, 2010): For the Intellectually Active, Alzheimer's Diagnosis Begins a Steep Slide

Publication Date: 
Wed, 09/01/2010

The vaulted protection that intellectually active adults get from Alzheimer's disease has a dark downside, a study released Wednesday has found. Once dementia symptoms become evident and Alzheimer's disease is diagnosed in such patients, their mental decline can come with frightening speed.

New York Times (September 1, 2010): Finding Suggests New Target for Alzheimer's Drugs

Publication Date: 
Wed, 09/01/2010

In a year when news about Alzheimer's disease seems to whipsaw between encouraging and disheartening, a new discovery by an 84-year-old scientist has illuminated a new direction.

The scientist, Paul Greengard, who was awarded a Nobel Prize in 2000 for his work on signaling in brain cells, still works in his Rockefellar University lab in New York City seven days a week, walking there from his apartment two blocks away, taking his aging Bernese mountain dog, Alpha.

New York Times (August 9, 2010): Spinal-Fluid Test is Found to Predict Alzheimer's

Publication Date: 
Mon, 08/09/2010

Researchers report that a spinal fluid test can be 100 percent accurate in identifying patients with significant memory loss who are on their way to developing Alzheimer's disease.

Although there has been increasing evidence of the value of this and other tests in finding signs of Alzheimer’s, the study, which will appear Tuesday in the Archives of Neurology, shows how accurate they can be. The new result is one of a number of remarkable recent findings about Alzheimer’s.

Bloomberg News (August 25, 2010): Link Between Diabetes, Alzheimer's Disease Strengthened

Publication Date: 
Wed, 08/25/2010

Two of the most common and dreaded illnesses in America may share a connection, with new research suggesting that having insulin resistance or type 2 diabetes raises your risk of developing the brain plaques associated with Alzheimer's disease.

After adjusting for other risk factors, the Japanese study found that people with the highest levels of fasting insulin had nearly six times the odds of having plaque deposits between nerves in the brain, compared to people with the lowest levels of fasting insulin.

Boston Globe (August 30, 2010): Using Venture World's Lessons to Battle Alzheimer's

Publication Date: 
Mon, 08/30/2010

When Henry McCance started at Greylock Partners in 1969, the venture capital industry had less than $100 million flowing into it each year, he estimates. Now, it's roughly a $20 billiion-a-year sector of the financial world that has backed companies whose products are, in many cases, staples of modern living.

Five years ago, McCance, now Greylock's chairman emeritus, started a nonprofit research foundation called the Cure Alzheimer's Fund.

Syndicate content